Dados B3 › QUSW3 × MLAS3 · Português
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | QUSW3 | MLAS3 | year |
|---|---|---|---|
| ROE | 22.7%! | 0.0% | 2025 |
| ROIC | 24.3%! | 3.3% | 2025 |
| ROA | 9.1%! | 2.3% | 2025 |
| Gross margin | 100.0%! | 24.7% | 2025 |
| EBIT margin | 60.7%! | 2.7% | 2025 |
| Net margin | 39.2%! | 3.1% | 2025 |
| Net debt/EBITDA | 1.28x! | -1.03x | 2025 |
| Current ratio | 1.03x! | 1.92x | 2025 |
| Revenue growth (1y) | -3.1%! | 15.8% | 2025 |
| Revenue growth (5y CAGR) | -12.7%! | 6.6% | 2025 |
| Piotroski F-Score | 4/9! | 7/9 | 2025 |
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | QUSW3 | MLAS3 | year |
|---|---|---|---|
| P/E | — | — | None × 2025 |
| P/B | — | 0.37x | None × 2025 |
| EV/EBITDA | — | 5.71x | None × 2025 |
| FCF yield | — | 6.8% | None × 2025 |
Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-08 14:45 UTC. If this does not match /saude, you are reading a cached copy.
Home · Methodology · Transparency · Audit it